Guan H - Search Results

1

Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience.

He L, Xiao J, Wei Z, He Y, Wang J, Guan H, Mu X, Peng X. He L, et al. Among authors: guan h. Oral Oncol. 2020 Aug 27;109:104978. doi: 10.1016/j.oraloncology.2020.104978. Online ahead of print. Oral Oncol. 2020. PMID: 32861986

2

Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.

He J, Cai L, Chen Y, He Y, Wang M, Tang J, Guan H, Wang J, Peng X. He J, et al. Among authors: guan h. Radiother Oncol. 2018 Oct;129(1):30-37. doi: 10.1016/j.radonc.2018.02.007. Epub 2018 Mar 5. Radiother Oncol. 2018. PMID: 29519627

3

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis.

He Y, Guo T, Guan H, Wang J, Sun Y, Peng X. He Y, et al. Among authors: guan h. Cancer Manag Res. 2018 Jun 6;10:1419-1428. doi: 10.2147/CMAR.S160469. eCollection 2018. Cancer Manag Res. 2018. PMID: 29922086 Free PMC article.

4

Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.

Wang J, Wang Y, He Y, Guan H, He L, Mu X, Peng X. Wang J, et al. Among authors: guan h. Trials. 2019 Nov 21;20(1):641. doi: 10.1186/s13063-019-3741-5. Trials. 2019. PMID: 31752981 Free PMC article.

5

Assessment of induction chemotherapy regimen TPF vs GP followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A retrospective cohort study of 160 patients.

Guan H, He Y, Wei Z, Wang J, He L, Mu X, Peng X. Guan H, et al. Clin Otolaryngol. 2020 Mar;45(2):274-279. doi: 10.1111/coa.13489. Epub 2019 Dec 13. Clin Otolaryngol. 2020. PMID: 31788988 No abstract available.

6

Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.

He Y, Zhao Z, Wang Y, Chai J, He J, Wang J, He L, Guan H, Wei Z, Liu Z, Mu X, Peng X. He Y, et al. Among authors: guan h. Head Neck. 2020 Aug;42(8):2067-2076. doi: 10.1002/hed.26141. Epub 2020 Mar 23. Head Neck. 2020. PMID: 32202686

7

Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites.

Mu X, Li Y, He L, Guan H, Wang J, Wei Z, He Y, Liu Z, Li R, Peng X. Mu X, et al. Among authors: guan h. Head Neck. 2021 Jan;43(1):48-59. doi: 10.1002/hed.26443. Epub 2020 Aug 30. Head Neck. 2021. PMID: 32864833

8

Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.

Wei ZG, Hu XL, He Y, Guan H, Wang JJ, He L, Mu XL, Liu ZR, Li RD, Peng XC. Wei ZG, et al. Among authors: guan h. Head Neck. 2021 May;43(5):1465-1475. doi: 10.1002/hed.26608. Epub 2021 Jan 9. Head Neck. 2021. PMID: 33421240

9

Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: Meta-analysis.

Guan H, He Y, Su Y, Wei Z, Liu Z, Wang J, He L, Mu X, Li R, Hu X, Peng X. Guan H, et al. Head Neck. 2021 Aug;43(8):2332-2341. doi: 10.1002/hed.26699. Epub 2021 Mar 31. Head Neck. 2021. PMID: 33792110

10

Survival outcomes in patients with parotid gland carcinoma treated with postoperative therapies using risk stratification.

Wei ZG, Peng XC, He Y, Guan H, Wang JJ, He L, Mu XL, Liu ZR, Li RD, Zhang Z. Wei ZG, et al. Among authors: guan h. Head Neck. 2021 Aug;43(8):2488-2496. doi: 10.1002/hed.26722. Epub 2021 Apr 28. Head Neck. 2021. PMID: 33908675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,667 results

Search Page

Filters